Karlsen S, Jordfald G, Svaar H
Urol Int. 1984;39(3):150-3. doi: 10.1159/000280964.
In a prospective study we have included the specific red cell adherence (SRCA) test for the identification of blood group isoantigens in the investigation of patients with bladder tumor. The preliminary results, relating the SRCA test to grade and stage in 50 patients are presented. None of the SRCA-positive tumors were of high-grade malignancy (WHO III), and only SRCA-negative tumors had invasive properties at the time of investigation. 8 of 9 patients with carcinoma in situ were SRCA-negative.
在一项前瞻性研究中，我们纳入了特异性红细胞黏附（SRCA）试验，用于在膀胱肿瘤患者的调查中鉴定血型同种抗原。本文展示了50例患者中SRCA试验与肿瘤分级和分期相关的初步结果。SRCA阳性的肿瘤均无高级别恶性（WHO III级），且在调查时只有SRCA阴性的肿瘤具有侵袭性。9例原位癌患者中有8例SRCA阴性。
